cTRL Therapeutics

We’re excited to present new data at the upcoming?Society for Immunotherapy of Cancer (SITC) Annual Meeting from November 6-10 in Houston! Join us as we showcase the latest advancements in our?#CellTherapy?platform through two key posters. The two datasets highlight the intriguing efficacy characteristics of cTRLs, which make them an ideal cell type to address the growing unmet need in solid tumor treatment. We look forward to sharing these exciting developments at the conference. Come find us in the poster hall to learn more, and?check out our website at?www.ctrl-tx.com #SITC24 #Biotech #CancerResearch

We're #hiring a new Head of Platform Engineering in Chicago, Illinois. Apply today or share this post with your network.

At cTRL Therapeutics, we are committed to advancing the fight against #cancer by unlocking the full potential of cell therapy for more patients. As we push forward in our mission, we deeply appreciate the unwavering dedication of researchers and healthcare professionals who work tirelessly towards finding a cure. We also honor the incredible bravery of patients who participate in clinical trials, paving the way for new breakthroughs and hope for the future. Discover more about cTRLs and how we're advancing cell therapies to help patients with cancer at www.ctrl-tx.com. #WorldCancerResearchDay #Biotech #CellTherapy

Happy #WomensEqualityDay! Today, we celebrate the achievements, strength, and resilience of women everywhere. At cTRL, embracing diverse perspectives makes us stronger, more innovative, and more compassionate. Here's to the women scientists, doctors, patients, and advocates who inspire us every day. Let's continue to strive for a world where every woman has the opportunity to reach her full potential and where equality is the norm, not the exception. #Biotech #CellTherapy

We are thrilled to introduce another new member of the cTRL family! Please join us in welcoming Kanak Joshi, Senior Scientist, T-cell Engineering. With a background in Immunology and Cancer Biology, Kanak is passionate about developing cutting-edge cell-based therapies and personalized medicine for cancer treatment. Beyond the professional setting, Kanak loves playing basketball, cooking, watching movies and exploring the world. Kanak will help to further our mission to unlock the next generation of solid tumor #cancer therapies. Welcome to the team! #NewHire #EmployeeSpotlight #WelcomeToTheTeam #Biotech #CellTherapy

At cTRL, we are aiming to unlock the next generation of solid tumor cancer therapies through cTRLs, a rare and potent circulating T cell population found in the blood and naturally equipped to fight #cancer. This is enabled by our proprietary #IsoQore technology, which gently isolates cTRLs in large quantities with unprecedented speed and purity in a manner that is built to scale. Learn more about our novel platform here: https://lnkd.in/e75_wUS7 #Biotech #CellTherapy

Get to know some of the talented individuals driving our success! Both team members bring unique skills and perspectives that contribute to our mission of unlocking the next generation of solid tumor #cancer therapies. Shivu Sharma, Head of Strategy & Business Development, has over a decade of strategic leadership in oncology and cell therapy. He previously led product and portfolio strategy at Instil Bio and held key roles at Gilead Sciences and Kite Pharma, contributing to their strategic decisions and the Kite acquisition. Shivu also founded Big Pharma Sharma, a Substack publication offering industry insights. Vita Salsman, Head of Cell Therapy Manufacturing, has 19 years of experience in cell and gene therapy for solid tumors and has worked alongside scientific, regulatory, and clinical teams, bringing much needed new therapy options to critical patient populations, both adults and pediatrics. Leveraging her expertise in manufacturing operations, clinical trial logistics, and quality programs, her pivotal work has led to 8 completed phase I/II trials, treating a wide range of indications, including GBM, advanced sarcoma, and breast cancer. #EmployeeSpotlight #Biotech #CellTherapy

At cTRL, embracing diversity is one of our core values. As we celebrate #PrideMonth and #Juneteenth, we are reminded of the strength that comes from including and uplifting every unique voice in our community. Pride Month honors the courage and resilience of the LGBTQ+ community, while Juneteenth commemorates the emancipation of enslaved African Americans and the ongoing pursuit of freedom and equality. Both observances highlight the importance of acceptance, inclusion, and the relentless pursuit of justice. In the world of #cancer biotech, #diversity fuels our mission to develop groundbreaking treatments and solutions. By bringing together diverse perspectives, we foster creativity, drive progress, and enhance our ability to address the complex challenges of cancer. Let's celebrate diversity as a strength and make it part of the biotech industry's DNA. Together, we can create a future where everyone thrives. #Biotech #CellTherapy

As we observe #NationalWomensHealthWeek, we're reminded of the unique challenges and triumphs that women face in their healthcare journeys. At cTRL, we're committed to empowering women with innovative solutions and personalized care in the fight against #cancer. Together, we can break down barriers and foster a future where every woman has the support and resources she needs to thrive. Join us in honoring this week by raising awareness, promoting education, and advocating for the well-being of women everywhere. #NWHW #Biotech #CellTherapy

At cTRL, every month is dedicated to advancing the fight against #cancer. However, this #NationalCancerResearchMonth, we're especially proud to recognize and spotlight the incredible efforts of our team and collaborators in the journey for innovative treatments and cures. Through relentless research and groundbreaking discoveries, we're committed to revolutionizing cancer care and improving patient outcomes. We are harnessing the power of cTRLs – a rare and potent circulating T cell population found in the blood and naturally equipped to fight cancer – to engineer solid tumor cell therapies. Learn more about our unique approach to harness the power of cTRLs at www.ctrl-tx.com #NCRM #Biotech #CellTherapy